Ardent Health Q2 revenue up 12% to $1.65B; Adj EBITDA +39% to $170M; reaffirms FY25 guidance

Ardent Health, Inc.

2025-Q2 EPS reported $0.81 revenue$3,142,514,000

Net income $73M ($0.52 diluted EPS) vs $43M ($0.34) prior year; adjusted EBITDA $170M.
Total revenue $1.645B (+11.9% YoY) driven by 1.6% adjusted admission growth and 10.2% revenue per adjusted admission.
Admissions +6.6% YoY; inpatient surgeries +9.2% but outpatient surgeries -3.8%.
Lease-adjusted net leverage ratio improved to 2.7x from 3.0x in Q1; available liquidity $835M.
Reaffirms FY25 guidance: revenue $6.2-6.45B, Adj EBITDA $575-615M, diluted EPS $1.73-2.01.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.